Status:
COMPLETED
Bleeding Ulcer and Erosions Study "BLUE Study"
Lead Sponsor:
Ostfold Hospital Trust
Collaborating Sponsors:
University Hospital, Akershus
Conditions:
Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Peptic Ulcer
Eligibility:
All Genders
18+ years
Brief Summary
A prospective study of bleeding peptic ulcers and/or erosions in the upper gastrointestinal tract - risk-medication, presence of Helicobacter pylori, treatment and outcome.
Detailed Description
Patients admitted to hospital due to hematemesis and/or melena with endoscopic finding of ulcer and/or erosion in the ventricle and/or duodenum are eligible for inclusion in the BLUE study after an in...
Eligibility Criteria
Inclusion
- Patients over 18 years who consent to be enrolled in the study
- Patients with hematemesis and/or melena, anemia or positiv FOBT that during gastroscopy are diagnosed with ulcer and/or erosions of the ventricle and/or duodenum.
- Gastroscopy must be performed within 24 hours of the findings above.
Exclusion
- Patients who do not wish to participate or are not competent to give consent.
- Patients that due to language problems or other reasons do not understand the content of the information about the study.
- Patients with erosions without hematemesis, in whom one diagnose possible bleeding source on colonoscopy.
- Patients with malignant ulcer, ulcer simplex or cameron lesions.
Key Trial Info
Start Date :
March 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
543 Patients enrolled
Trial Details
Trial ID
NCT03367897
Start Date
March 1 2015
End Date
July 1 2019
Last Update
November 18 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Akershus University Hospital
Oslo, Norway
2
Ostfold Hospital Trust
Sarpsborg, Østfold fylke, Norway